Founded with a mission to revolutionize drug delivery, Novel Therapeutic Technologies (NTT) focuses on developing advanced systems that enhance the penetration and efficiency of topical medications. Their flagship product, Ethosome technology, significantly improves drug absorption, thereby increasing therapeutic efficacy and reducing side effects. NTT collaborates with pharmaceutical companies globally to introduce innovative and effective treatments, aiming to improve patient outcomes and quality of life.

NTT has garnered attention from notable figures in the pharmaceutical industry and has secured investments from leading healthcare venture capital firms. The company’s Ethosome technology has been widely recognized for its potential to transform drug delivery methods, earning accolades and fostering partnerships with top-tier pharmaceutical companies. Through these collaborations, NTT has made a substantial impact on the market, setting new standards in drug delivery and patient care.